CIK 0001714899
- Large accelerated filer
Denali Therapeutics Inc.
Sign in to watch- Ticker
- DNLI
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 463872213
- Phone
- +1 650-866-8547
- Business address
- 161 OYSTER POINT BLVD., SOUTH SAN FRANCISCO, CA, 94080
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $363,678
- in 3 filings, $327K under 10b5-1 plans
Net −$363,678. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-05-31 | Harris Erik Director | Grant or award | +5,967 | 17,052 | ||
| 2024-05-31 | Harris Erik Director | Grant or award · Stock Option (right to buy) | +17,901 | 17,901 | ||
| 2023-06-01 | Harris Erik Director | Grant or award | +4,216 | 11,085 | ||
| 2023-06-01 | Harris Erik Director | Grant or award · Stock Option (right to buy) | +12,649 | 12,649 | ||
| 2022-02-03 | Harris Erik Director | Grant or award | +6,869 | 6,869 | ||
| 2022-02-03 | Harris Erik Director | Grant or award · Stock Option (right to buy) | +20,607 | 20,607 |
Page 1 of 1 · 6 trades